Patents by Inventor Cornelia Lechner

Cornelia Lechner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7371828
    Abstract: The present invention relates, in general, to an extracellular signal regulated kinase, ERK-5.
    Type: Grant
    Filed: June 16, 2003
    Date of Patent: May 13, 2008
    Assignee: Max-Planck-Gesellschaft zur Forderung der Wissenschaften E.V.
    Inventors: Cornelia Lechner, Niels P. Moller, Axel Ullrich
  • Publication number: 20030229209
    Abstract: The present invention relates, in general, to an extracellular signal regulated kinase, ERK-5.
    Type: Application
    Filed: June 16, 2003
    Publication date: December 11, 2003
    Applicant: Max-Planck-Gesellschaft zur Forderung der Wissenschaften
    Inventors: Cornelia Lechner, Niels Peter Moller, Axel Ullrich
  • Patent number: 6579972
    Abstract: The present invention relates, in general, to an extracellular signal regulated kinase, ERK-5.
    Type: Grant
    Filed: September 9, 1999
    Date of Patent: June 17, 2003
    Assignee: Max-Planck-Gesellschaft zur Forderung der Wissenschaften, e.V.
    Inventors: Cornelia Lechner, Niels Peter Møller, Axel Ullrich
  • Patent number: 6030822
    Abstract: The present invention relates, in general, to an extracellular signal regulated kinase, ERK-5.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: February 29, 2000
    Assignee: Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V.
    Inventors: Cornelia Lechner, Niels Peter M.o slashed.ller, Axel Ullrich
  • Patent number: 5459036
    Abstract: The present invention relates, in general, to an extracellular signal regulated kinase, ERK-5. In particular, the present invention relates to nucleic acid molecules coding for ERK-5; ERK-5 polypeptides; recombinant nucleic acid molecules; cells containing the recombinant nucleic acid molecules; antisense ERK-5 nucleic acid constructs; antibodies having binding affinity to an ERK-5 polypeptide; hybridomas containing the antibodies; nucleic acid probes for the detection of ERK-5 nucleic acid; a method of detecting ERK-5 nucleic acid or polypeptide in a sample; kits containing nucleic acid probes or antibodies; a method of detecting a compound capable of binding to ERK-5 or a fragment thereof; a method of detecting an agonist or antagonist of ERK-5 activity; a method of agonizing or antagonizing ERK-5 associated activity in a mammal; and a pharmaceutical composition comprising an ERK-5 agonist or antagonist.
    Type: Grant
    Filed: March 19, 1993
    Date of Patent: October 17, 1995
    Assignee: Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V.
    Inventors: Cornelia Lechner, Niels P. H. Moller, Axel Ullrich